Drugmaker Developing Abuse-Deterrent Painkiller

BOSTON (CBSMiami/AP) —A company which makes a powerful new painkiller is selling its migraine therapy business in order to focus on developing abuse-resistant forms of the drug.

Zogenix Chief Executive Officer Roger Hawley said the sale will help the company focus on the launch of Zohydro ER while providing capital "to continue the development of two abuse-deterrent formulations" of the opioid, Zohydro.

The company announced in November it would pursue an abuse-deterrent form of the drug.

Health officials around the country worry addicts will crush Zohydro capsules and then snort or inject the drug to get high.

Citing such worries, Massachusetts Gov. Deval Patrick tried to ban the drug, but a federal court blocked the state from enforcing the ban. Patrick has since announced new restrictions on the drug.

TM and © Copyright 2014 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2014 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.